Meeting the Challenges Facing Emerging GxP Regulated Organizations in the Life Sciences Recording 11

USDM Life Sciences

/@usdatamanagement

Published: July 2, 2015

Open in YouTube
Insights

This video provides an in-depth exploration of the challenges faced by emerging GxP regulated organizations in the life sciences, particularly concerning the implementation and management of IT systems. Larry Isaacson, a practice leader at USDM Life Sciences, outlines common pitfalls and best practices for companies transitioning into regulated operations, emphasizing the importance of proactive compliance management to save time, money, and aggravation. The discussion moves beyond specific system validations to address the underlying organizational maturity and cultural shifts required to effectively manage GxP compliance for IT.

The presentation introduces the concept of a "compliance maturity challenge," drawing parallels to well-known maturity models like CMMI in software engineering and enterprise architecture. Isaacson highlights that organizations often operate at lower maturity levels (e.g., "heroic efforts" or "reactive mode") when it comes to GxP IT compliance, leading to inefficient, costly, and often after-the-fact remediation efforts. He details a five-level maturity model, from unpredictable and reactive processes to optimized and integrated quality management, advocating for organizations to strive for at least level three ("defined") to significantly improve their compliance posture and operational efficiency. The speaker also presents a compliance risk model, illustrating how regulatory compliance is the pinnacle achieved through the alignment of administrative procedures, personnel management, infrastructure, applications, and business processes, emphasizing that any weak link can jeopardize overall compliance.

A significant portion of the webinar is dedicated to explaining why GxP compliance is challenging for emerging organizations. Isaacson points to factors such as trial-and-error approaches, a cultural aversion to formal processes, lack of separation of duties, and a focus on outcomes rather than repeatable processes. He then outlines critical success factors, including the recognition of the need for system validation, organizational structure adjustments, acceptance of formal procedures, structured testing, and a champion for quality and change. The discussion further breaks down the maturity model across specific GxP considerations like computer system validation capabilities, quality organization, IT organization maturity, documentation, change management, approval authority, communication, and quality system tools, ultimately recommending a move towards integrated eQMS suites and risk-based processes.

The webinar concludes with actionable recommendations for approaching compliance, such as recognizing emerging requirements, establishing a quality authority early, forming cross-functional teams, and prioritizing education. Isaacson strongly advises using established methodologies like GAMP 5, reconciling competing quality systems, simplifying review processes, and educating IT on GxP best practices. He also cautions against underestimating the risks associated with SaaS architectures and outsourcing, stressing the importance of early assessment of SOP impacts and adherence to a full system lifecycle (requirements, design, testing, maintenance, retirement). The core message is that proactive, integrated, and risk-adjusted compliance management, driven by a clear quality authority and continuous education, is essential for avoiding audit findings and achieving sustainable operational excellence in regulated life sciences.

Key Takeaways:

  • Compliance Maturity is Critical: Organizations often struggle with GxP compliance due to low organizational maturity, leading to reactive, costly, and inefficient "heroic efforts" rather than structured, repeatable processes. Aim for at least level three ("defined") in a compliance maturity model.
  • GxP IT Compliance is Foundational: Regulatory compliance is built upon a pyramid of aligned administrative procedures, personnel, infrastructure, applications, and business processes. A weakness in any layer, especially IT, can compromise overall compliance.
  • Common Organizational Challenges: Emerging regulated organizations often face cultural aversion to formal processes, lack of separation of duties, a sole focus on outcomes, and resistance to a compliance-aware culture, which must be overcome.
  • Critical Success Factors for Compliance: Key to success are recognizing the need for system validation, adapting organizational structures, accepting formal procedures, implementing structured testing, establishing clear communication, improving IT maturity, and identifying a "champion of quality and change."
  • IT Organization as an Achilles Heel: IT organizations often lag in GxP awareness, operating with ad hoc processes and a technology-oriented rather than business-oriented culture, making them a common weak link in compliance efforts.
  • Embrace Established Methodologies: Utilize recognized frameworks like GAMP 5 as a foundation for compliance. These are accepted by regulatory bodies and auditors, providing a scalable and quick-start approach with standard templates. Avoid "newfangled flexible approaches" that require educating auditors.
  • Risk-Based Approach to Validation: Scale validation and qualification efforts to the inherent risk of the system. This saves significant money and time by focusing resources where they are most needed, rather than applying rigid, comprehensive validation to every project.
  • Early Quality Authority and Cross-Functional Teams: Establish a clear quality authority (internal or outsourced) as early as possible. Form cross-functional teams involving IT, business, and quality to address GxP compliance needs collaboratively from inception.
  • Educate IT on GxP Compliance: Provide early and targeted education to IT personnel on GxP IT compliance best practices. Help them understand that their servers, hardware, networks, and applications are essentially regulated equipment once in scope for a regulated system.
  • Prioritize SOP Assessment and Development: Do not leave Standard Operating Procedures (SOPs) until the end of a project. Assess their impact early, ensure they exist, are updated, and are comprehensive, as late assessment can unwind significant validation efforts.
  • Beware of SaaS and Outsourcing Risks: Do not underestimate the compliance risks of moving to Software-as-a-Service (SaaS) or outsourcing applications/hosting. Involve IT and compliance teams early to assess vendors and arrangements, as poorly positioned partners can lead to significant issues.
  • Full Lifecycle Management: Regulated systems require a full lifecycle approach, from requirements and design to formal testing (IQ, OQ, PQ), maintenance, and structured retirement, including data retention considerations.
  • Justifying Investment: To justify compliance investments, use external experience, examples of FDA compliance letters (e.g., 43s), and case studies demonstrating the money and time saved by proactive management versus reactive remediation.
  • Integrated Quality System Tools: Move from fragmentary eQMS systems (separate document control, CAPA, change control) to a comprehensive eQMS suite that integrates all quality management functions for a holistic view and easier audit management.

Key Concepts:

  • GxP: A general term for Good Practice quality guidelines and regulations. The "x" stands for the specific field, e.g., GMP (Good Manufacturing Practice), GCP (Good Clinical Practice), GLP (Good Laboratory Practice).
  • Compliance Maturity Challenge: The problem organizations face in evolving their processes and culture to meet regulatory compliance requirements effectively and efficiently, often starting from an unpredictable, reactive state.
  • CMMI (Capability Maturity Model Integration): A process improvement approach that helps organizations improve their performance. The video references its application to software engineering and general organizational maturity.
  • GAMP 5 (Good Automated Manufacturing Practice 5): A guideline for validating automated systems in pharmaceutical manufacturing, widely accepted for computer system validation in regulated environments.
  • Validation Accelerator Packs (VAPs): Pre-configured documentation and templates designed to speed up the validation process for specific systems or platforms.
  • eQMS Suite (Electronic Quality Management System Suite): An integrated software solution that manages all aspects of quality and compliance, including document control, training, CAPA, audit management, and change control.
  • IQ/OQ/PQ (Installation Qualification/Operational Qualification/Performance Qualification): A three-stage process for validating equipment and systems, ensuring they are installed correctly, operate according to specifications, and perform consistently under actual use conditions.
  • 21 CFR Part 11: Regulations issued by the FDA that set forth requirements for electronic records and electronic signatures, ensuring their trustworthiness, reliability, and equivalence to paper records.